Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Laura Von Schantz"'
Autor:
Barnabas Nyesiga, Mattias Levin, Anna Säll, Anna Rosén, Kim Jansson, Sara Fritzell, Karin Hägerbrand, Dietmar Weilguny, Laura von Schantz
Publikováno v:
mAbs, Vol 16, Iss 1 (2024)
ABSTRACTDespite the large number of existing bispecific antibody (bsAb) formats, the generation of novel bsAbs is still associated with development and bioprocessing challenges. Here, we present RUBY, a novel bispecific antibody format that allows ra
Externí odkaz:
https://doaj.org/article/3554ed116f6c45079b118217d1d8fd6f
Autor:
Malin Lindstedt, Peter Ellmark, Lennart Greiff, Karin Hägerbrand, Laura von Schantz, Mia Thagesson, Doreen Werchau, Kristine Smedenfors, Anna Rosén, Anette Sundstedt, Adnan Deronic, Lill Ljung, Mattias Levin, Laura Varas, Anna Säll, Christina Sakellariou, Barnabas Nyesiga, David Gomez Jimenez, Mona Celander, Deniz Bölükbas, Fredrika Carlsson
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 11 (2022)
Background Indications with poor T-cell infiltration or deficiencies in T-cell priming and associated unresponsiveness to established immunotherapies represent an unmet medical need in oncology. CD40-targeting therapies designed to enhance antigen pr
Externí odkaz:
https://doaj.org/article/3ded16f9cf504c5983b33e362b58d5fd
Autor:
Peter Ellmark, Karin Hägerbrand, Mia Thagesson, Doreen Werchau, Anna Rosén, Karin Barchan, Anette Sundstedt, Adnan Deronic, Lill Ljung, Mattias Levin, Laura Von Schantz, Laura Varas, Anna Säll, Barnabas Nyesiga, Eva Lindqvist
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/9e6a3658910c424b887736939f0b115c
Autor:
Anne Månsson Kvarnhammar, Niina Veitonmäki, Karin Hägerbrand, Anna Dahlman, Karin Enell Smith, Sara Fritzell, Laura von Schantz, Mia Thagesson, Doreen Werchau, Kristine Smedenfors, Maria Johansson, Anna Rosén, Ida Åberg, Magnus Winnerstam, Eva Nyblom, Karin Barchan, Christina Furebring, Per Norlén, Peter Ellmark
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-14 (2019)
Abstract Background The CTLA-4 blocking antibody ipilimumab has demonstrated substantial and durable effects in patients with melanoma. While CTLA-4 therapy, both as monotherapy and in combination with PD-1 targeting therapies, has great potential in
Externí odkaz:
https://doaj.org/article/ac146a36143540ed83d59ae4ac9773f4
Autor:
Peter Ellmark, Karin Hägerbrand, Doreen Werchau, Anna Rosén, Karin Barchan, Adnan Deronic, Mattias Levin, Laura Von Schantz, Laura Varas, Anna Säll, Lill Ljug, Mia Thageson, Christina Sakellariou
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/bc293d52dd564f1e929282860de5f171
Publikováno v:
BioResources, Vol 5, Iss 2, Pp 796-807 (2010)
Recent studies on the ultrastructure and composition of the gelatinous layer (g-layer) in poplar have reported findings of xyloglucan. Using correlated fluorescence, scanning- and transmission electron micros-copy, we found evidence for xyloglucan pr
Externí odkaz:
https://doaj.org/article/d5f36b387a234bd4b985a1022ec7802a
Autor:
Peter Ellmark, Gabriela Hernandez-Hoyos, Maria Askmyr, Catherine J. McMahan, Laura von Schantz, David Bienvenue, Anna Dahlman, Anna Säll, Hilario J. Ramos, Niina Veitonmäki, Anette Sundstedt, Peter Pavlik, Christina Furebring, Jane Gross, Maria Håkansson, Nadia Rose, Laura A. Varas, Lena Schultz, Allison G. Chunyk, Adnan Deronic, Robert Bader, Lill Ljung, Lynda Misher, Anneli Nilsson, Danielle Van Citters, Doreen Werchau, Robert Miller, Sara Fritzell, Michelle H. Nelson
4–1BB (CD137) is an activation-induced costimulatory receptor that regulates immune responses of activated CD8 T and natural killer cells, by enhancing proliferation, survival, cytolytic activity, and IFNγ production. The ability to induce potent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4fa7ca6e3077d149181e6c35ac0c32cf
https://doi.org/10.1158/1535-7163.c.6543583
https://doi.org/10.1158/1535-7163.c.6543583
Autor:
Peter Ellmark, Gabriela Hernandez-Hoyos, Maria Askmyr, Catherine J. McMahan, Laura von Schantz, David Bienvenue, Anna Dahlman, Anna Säll, Hilario J. Ramos, Niina Veitonmäki, Anette Sundstedt, Peter Pavlik, Christina Furebring, Jane Gross, Maria Håkansson, Nadia Rose, Laura A. Varas, Lena Schultz, Allison G. Chunyk, Adnan Deronic, Robert Bader, Lill Ljung, Lynda Misher, Anneli Nilsson, Danielle Van Citters, Doreen Werchau, Robert Miller, Sara Fritzell, Michelle H. Nelson
Supplementary figures and methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ed15b293d4cc182e6f45572e5544264
https://doi.org/10.1158/1535-7163.22523071.v1
https://doi.org/10.1158/1535-7163.22523071.v1
Autor:
Michelle H. Nelson, Sara Fritzell, Robert Miller, Doreen Werchau, Danielle Van Citters, Anneli Nilsson, Lynda Misher, Lill Ljung, Robert Bader, Adnan Deronic, Allison G. Chunyk, Lena Schultz, Laura A. Varas, Nadia Rose, Maria Håkansson, Jane Gross, Christina Furebring, Peter Pavlik, Anette Sundstedt, Niina Veitonmäki, Hilario J. Ramos, Anna Säll, Anna Dahlman, David Bienvenue, Laura von Schantz, Catherine J. McMahan, Maria Askmyr, Gabriela Hernandez-Hoyos, Peter Ellmark
Publikováno v:
Molecular cancer therapeutics. 22(1)
4–1BB (CD137) is an activation-induced costimulatory receptor that regulates immune responses of activated CD8 T and natural killer cells, by enhancing proliferation, survival, cytolytic activity, and IFNγ production. The ability to induce potent
Autor:
Barnabas Nyesiga, Mia Thagesson, Anna Rosén, Karin Hägerbrand, Mattias Levin, Karin Barchan, Laura Varas, Anette Sundstedt, Anna Säll, Doreen Werchau, Peter Ellmark, Lill Ljung, Laura Von Schantz, Eva Lindqvist, Adnan Deronic
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
BackgroundAlligator's Neo-X-Prime platform aims to enable antigen presenting cells to efficiently enhance priming of tumor neoantigen-specific T cells with the goal of overcoming PD-1 resistance in certain tumor types. We hypothesize that binding of